Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Sept. 6, 2022
Abstract
Background:
Cancer
patients
may
enhance
their
physical
function
and
quality
of
life
via
exercise.
However,
there
are
few
quantitative
data
to
determine
if
exercise
is
safe
effective
for
the
with
bone
metastases.
Methods:
Embase,
PubMed
Cochrane
Controlled
Trials
Register
Databases
were
searched
May
5,
2022.
Results:
692
items
found.
Five
studies
totaling
234
included
in
analysis
after
thorough
screening.
The
interventions
soccer,
aerobic
exercise,
resistance
training.
There
no
adverse
effects
connected
results
mixed-efficacy
study
showed
that
improved
mineral
density
more
than
regular
nursing
(P=0.009).
It
also
had
a
clinically
significant
effect
on
body
composition
pain,
but
was
difference
between
groups
(P
>
0.05).
Conclusions:
Exercise
seems
be
people
metastases,
it
can
increase
density,
improve
composition,
alleviate
pain.
British Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
131(6), P. 957 - 969
Published: June 27, 2024
We
proposed
the
Physical
Activity
and
Cancer
Control
(PACC)
framework
in
2007
to
help
organise,
focus,
stimulate
research
on
physical
activity
eight
cancer
control
categories:
prevention,
detection,
treatment
preparation/coping,
coping/effectiveness,
recovery/rehabilitation,
disease
prevention/health
promotion,
palliation,
survival.
This
perspective
paper
provides
a
high-level
overview
of
scientific
advances
across
categories,
summarises
current
guidelines,
updates
PACC
framework,
identifies
remaining
emerging
knowledge
gaps,
future
directions.
Many
have
been
made
that
are
reflected
updated
guidelines
for
six
categories
apart
from
detection
palliation.
Nevertheless,
minimal
optimal
type,
dose,
timing
remain
unknown,
especially
understudied
population
subgroups
defined
by
age,
race/ethnicity,
resource
level
regions/countries.
To
achieve
full
benefit
control,
should
use
innovative
study
designs
include
diverse
at-risk
populations
sites.
Additionally,
effective
behaviour
change
strategies
needed
increase
levels
implementation
science
accelerate
translation
evidence
generation
into
practical,
real-world
interventions.
Cancer,
Journal Year:
2023,
Volume and Issue:
129(23), P. 3697 - 3712
Published: Oct. 3, 2023
Abstract
Background
Obesity
has
been
recognized
as
a
risk
factor
in
the
development
and
recurrence
of
breast
cancer
is
also
associated
with
poor
prognostic
outcomes.
This
systematic
review
network
meta‐analysis
aimed
to
identify
most
effective
exercise,
physical
activity,
dietary
interventions
reduce
fat
mass,
body
percentage
weight
well
potentially
increase
lean
mass
women
diagnosed
or
at
high
cancer.
Methods
A
search
databases
was
performed
up
May
2022.
Eligible
randomized
controlled
trials
examined
effects
activity
and/or
on
random‐effects
conducted
determine
different
across
outcomes
when
sufficient
studies
were
available.
Results
Eighty‐four
(
n
=
6428)
included
this
review.
Caloric
restriction
combined
exercise
+
caloric
significantly
reduced
(range,
–3.9
–3.7
kg)
–5.3
–4.7
kg),
whereas
(–2.4%;
95%
confidence
interval
[CI],
–3.4%
–13%)
index
(–2.2
kg
×
m
–2
;
CI,
–3.0
–1.4
)
patients.
Resistance
intervention
(0.7
kg;
0.5–1.0
Conclusion
Multimodal
diet
programs
percentage,
preserve
mass.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 13, 2024
This
review
critically
evaluates
the
substantial
role
of
exercise
in
enhancing
cancer
prevention,
treatment,
and
patient
quality
life.
It
conclusively
demonstrates
that
regular
physical
activity
not
only
reduces
risk
but
also
significantly
mitigates
side
effects
therapies.
The
key
findings
include
notable
improvements
fatigue
management,
reduction
cachexia
symptoms,
enhancement
cognitive
functions.
Importantly,
elucidates
profound
impact
on
tumor
behavior,
modulation
immune
responses,
optimization
metabolic
pathways,
advocating
for
integration
into
standard
oncological
care
protocols.
refined
abstract
encourages
further
exploration
application
as
a
pivotal
element
management.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(24), P. 5044 - 5044
Published: Dec. 8, 2023
Gastrointestinal
(GI)
cancers
constitute
over
25%
of
global
cancer
cases
annually,
with
hepato-pancreato-biliary
(HPB)
presenting
particularly
poor
prognosis
and
challenging
surgical
treatments.
While
advancements
in
clinical
care
have
improved
post-operative
outcomes
time,
surgery
for
HPB
remains
associated
high
morbidity
mortality
rates.
Patients
are
often
older,
diagnosed
at
later
stages,
a
higher
prevalence
co-morbid
conditions,
leading
to
reduced
life
expectancy,
suboptimal
recovery,
increased
recurrence
risk.
Exercise
nutrition
interventions
emerged
as
safe
non-pharmacological
strategies
enhance
among
survivors,
but
their
potential
the
pre-operative
period
patients
underexplored.
This
narrative
review
evaluates
existing
evidence
on
exercise
nutritional
during
prehabilitation
populations,
focusing
clinically
relevant
related
frailty
malnutrition.
We
conducted
literature
search
PubMed
Google
Scholar
databases
identify
studies
utilizing
intervention
populations
components.
The
currently
available
suggests
that
incorporating
into
programs
offers
critical
opportunity
outcomes,
mitigate
risk
comorbidities,
support
overall
survivorship
populations.
underscores
need
further
research
optimize
timing,
duration,
components
programs,
emphasizing
patient-centered,
multidisciplinary
approaches
this
evolving
field.
Actual Problems of Nephrology,
Journal Year:
2025,
Volume and Issue:
34-35, P. 33 - 41
Published: Feb. 25, 2025
Вступ.
Рак
–
це
катаболічне
запальне
захворювання,
яке
призводить
до
того,
що
па-
цієнти
часто
відчувають
втрату
ваги
або
навіть
кахексію
у
важких
випадках.
Нутри-
тивна
недостатність
(НН)
є
важливим
ускладненням
раку.
Пацієнти
мають
високий
ризик
недоїдання
через
саму
хворобу
та
застосовувані
методи
лікування.
Недостатнє
споживання
їжі
розлади
харчової
поведінки
можуть
виникнути
з
багатьох
при-
чин:
сухість
роті,
кишкова
непрохідність,
мальабсорбція,
запор,
діарея,
блювота,
зниження
перистальтики
кишечника,
хемосенсорні
зміни
побічна
дія
ліків.
Мета.
Виділити
групи
онкологічних
пацієнтів,
які
виникнення
нутритивної
недостатності
обґрунтувати
необхідність
корекції
харчування.
Матеріали
і
методи.
Проведено
літературний
пошук
проаналізовано
відповідні
статті.
Відносно
недавні
роботи,
а
також
великі
серії
роботи
експертних
цен-
трів
включені
списку
літератури.
Результати
їх
обговорення.
НН
провісником
тривалості
життя,
оскільки,
за
оцінками,
вона
причиною
смерті
20%
хворих
на
рак.
Рання
оцінка
харчування
дієтичне
втручання
знизити
смертність
захворюваність
пацієнтів
раком.
Скринінг
дозволяє
ранньо
виявити
недоїдання,
відповідна
може
призвести
сприятливих
результатів
стані
якості
життя.
В
даний
час
не
існує
єдиного
стандартного
методу
оцінки
при
Отже,
єди-
ною
надійною
стратегією
для
отримання
правдивої
картини
стану
паці-
єнта
комплексний
аналіз
усіх
аспектів
пацієнта.
Оцінка
включає
антропометричні
вимірювання
оцінку
білка
в
організмі,
жиру
маркерів
запалення
імунних
маркерів.
Ретельне
клінічне
обстеження,
врахо-
вує
історію
хвороби
фізичні
ознаки,
схеми
пацієнта,
важливими
компонентами
Ранній
скринінг
має
першочергове
значення
швидкого
виявлення
потребують
критич-
ного
втручання,
спробі
забезпечити
найкращу
допомогу
хворим
рак
затримати
погіршення.
Висновок.
Розуміння
масштабу
проблеми
яких
групах
найбільша
потреба,
життєво
кроком
розпізнавання
лікування
онкологічної
Всі
онкологічні
пацієнти
повинні
проходити
регулярний
щодо
ризику
недостатності.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(8), P. 1271 - 1271
Published: April 9, 2025
Background/Objectives:
Paclitaxel
is
a
type
of
small
molecule
chemotherapy
widely
used
for
breast
cancer,
but
its
clinical
efficacy
often
hindered
by
dose-limiting
toxicities
such
as
chemotherapy-induced
peripheral
neuropathy
and
neutropenia.
Traditional
dosing
based
on
body
surface
area
does
not
account
variations
in
composition,
which
may
influence
paclitaxel
metabolism,
toxicity,
treatment
outcomes.
This
review
explores
the
interplay
between
physical
activity,
pharmacokinetics,
emphasizing
potential
personalized
strategies.
Methods:
A
comprehensive
narrative
was
conducted
analyzing
literature
chemotherapy-related
toxicities,
exercise
oncology.
Studies
examining
role
skeletal
muscle
mass,
adipose
tissue,
activity
modulating
metabolism
side
effects
were
included.
Results:
Evidence
suggests
that
patients
with
low
mass
are
at
higher
risk
paclitaxel-induced
due
to
altered
drug
distribution
clearance.
Sarcopenic
obesity,
characterized
high-fat
levels,
further
exacerbates
these
risks.
Exercise,
particularly
resistance
aerobic
training,
has
been
shown
improve
mitigate
enhance
tolerance.
However,
precise
mechanisms
influences
pharmacokinetics
remain
underexplored.
Conclusions:
Personalized
dosing,
considering
composition
optimize
Future
research
should
focus
integrating
interventions
into
oncology
care
refining
models
interindividual
differences
metabolism.
These
advancements
could
while
minimizing
cancer
patients.
Current Oncology Reports,
Journal Year:
2024,
Volume and Issue:
26(2), P. 164 - 174
Published: Jan. 9, 2024
Abstract
Purpose
of
Review
The
goal
this
review
was
to
examine
the
role
and
practical
applications
integrative
oncology
strategies
in
supporting
immune
checkpoint
inhibitor
(ICI)
treatment
adult
solid
tumours.
Recent
Findings
Beyond
tumour-intrinsic
factors,
several
patient-associated
factors
affect
ICI
response,
including
germline
genetics,
systemic
inflammation,
gut
microbiota,
diet.
Current
promising
supportive
interventions
include
a
Mediterranean-style
diet
with
over
20
g
fibre,
regular
exercise,
use
live
biotherapeutics,
minimisation
PPI
antibiotic
use,
ensuring
vitamin
D
repletion,
many
other
approaches
under
study.
Caution
around
medical
cannabis
patients
on
ICIs
is
advised
due
previously
documented
adverse
impact
overall
survival,
while
VAE
(
Viscum
album
extract)
therapy
studies
have
not
highlighted
any
safety
concerns
so
far.
Summary
With
expanding
it
important
investigate
apply
low-cost
support
better
outcomes
minimise
events.
Further
research
may
lead
pre-treatment
assessment
both
tumour
biomarkers
personalised
multimodal
prehabilitation
care
plans,
as
well
on-treatment
targeted
nutrition,
physical
activity,
supplementation
regimes,
inflammation
microbiome
modulating
strategies.
Given
emerging
understanding
chronic
stress
outcomes,
mind-body
require
further
investigation.
Cancer Medicine,
Journal Year:
2023,
Volume and Issue:
12(7), P. 8804 - 8814
Published: Jan. 16, 2023
Abstract
Background
Cancer
supportive
care
interventions
often
have
limited
generalizability,
goal
misalignment,
and
high
costs.
We
developed
piloted
a
health
coaching
intervention,
UNC
HealthScore,
in
patients
undergoing
cancer
treatment
(
ClinicalTrials.gov
identifier
NCT04923997).
present
feasibility,
acceptability,
preliminary
outcome
data.
Methods
HealthScore
is
six‐month,
theory‐based,
multicomponent
intervention
delivered
through
participant‐driven
sessions.
For
the
pilot
study,
participants
were
provided
Fitbit,
responded
to
weekly
symptom
physical
function
digital
surveys,
met
with
coach
develop
monitor
goals.
Coaching
notes
discussed
interdisciplinary
team
meetings
back
treating
oncology
team.
Symptom
alerts
monitored
triaged
study
resource
nurse
relevant
services.
Feasibility
was
determined
based
on
enrollment
completion.
Acceptability
satisfaction
Fitbit‐wearing
informed
by
semistructured
exit
interviews.
Outcomes
evaluated
for
signs
of
improvement
included
several
PROMIS
(Patient‐Reported
Measurement
Information
System)
measures,
including
primary
target,
function.
Results
From
May
2020
March
2022,
50
completed
single‐arm
pilot.
high:
66%
enrolled
71%
full
intervention.
Participants
reported
an
average
4.8
4.7
(out
5)
acceptability
calls
using
respectively.
Physical
scores
rose
3.1
points
(SE
=
1.1)
from
baseline
3
months,
4.3
1.0)
6
above
established
minimal
clinically
important
difference
(MCID).
Improvements
MCID
also
evident
anxiety
depression,
smaller
improvements
demonstrated
emotional
support,
social
isolation,
cognitive
function,
burden,
self‐efficacy.
Discussion
shows
promising
outcomes.
Randomized
studies
are
underway
determine
efficacy
preserving
advanced
cancer.
Lipids in Health and Disease,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Oct. 14, 2022
Visceral
obesity
is
associated
with
cancer
incidence
and
prognosis.
Altered
lipid
profiles
are
frequently
seen
in
visceral
obese
patients.
The
blood
test
of
more
convenient
has
no
radical
side
effects
than
computed
tomography
(CT),
which
presently
the
most
accurate
way
to
measure
fat
area.
This
article
aims
investigate
associations
between
gastrointestinal
patients.In
total,
399
patients
newly
diagnosed
were
enrolled
this
observational
study.
Lipid
obtained
from
samples,
mass
area
(VFA)
was
measured
by
CT.
VFA
≥
100
cm2
considered
obesity.
under
receiver
operating
characteristic
curve
(AUROC)
utilized
evaluate
prognostic
powers
parameters
for
viscerally
patients.Patients
who
had
higher
triglyceride
(TG)
levels
(1.20
±
0.60
vs.
0.87
0.57
mmo/L,
P
<
0.001),
total
cholesterol
(TC)
(3.57
0.84
3.40
0.82,
=
0.044),
low-density
lipoprotein
(LDL-C)
(2.08
0.66
1.94
0.66,
0.047)
lower
high-density
(HDL-C)
(0.88
0.24
1.00
0.26,
0.001)
those
normal
group.
TG
positively
correlated
(r
0.299,
while
HDL-C
inversely
-0.237,
0.001).
predictive
capacity
at
cutoff
0.92
mmol/L
(AUROC
0.700,
95%
CI,
0.653-0.745,
0.98
0.585-0.682,
respectively.
>
linked
an
increased
risk
(OR
4.068,
2.338-7.079,
0.001).Lipid
significantly
VFA.
Gastrointestinal
elevated
Chinese
population.
Identifying
taking
proper
actions
cancers
helpful
overall
tumor